Spencer G Van Decar (Spencer Van Decar)

ORCID

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Venues

Journal of surgical oncology

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Elizabeth L Carpenter, Spencer G Van Decar, Patrick M McCarthy, Franklin A Valdera, Alexandra M Adams, Anne E O'Shea, Todd R Smolinsky, Katryna Thomas, Guy T Clifton, Timothy E Newhook, George E Peoples, Daniel W Nelson, Timothy J Vreeland
The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on response to neoadjuvant therapy. Journal of surgical oncology 130 (1) (2024)
Elizabeth L Carpenter, Spencer G Van Decar, Patrick M McCarthy, Franklin A Valdera, Alexandra M Adams, Anne E O'Shea, Todd R Smolinsky, Katryna Thomas, Guy T Clifton, Timothy E Newhook, George E Peoples, Daniel W Nelson, Timothy J Vreeland
The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on response to neoadjuvant therapy. Journal of surgical oncology (2024)
Elizabeth Lee Carpenter, Spencer G Van Decar, Alexandra M Adams, Anne E O'Shea, Patrick M McCarthy, Robert Connor Chick, Guy Travis Clifton, Timothy J Vreeland, Franklin A Valdera, Ankur Tiwari, Diane Hale, Phillip Kemp Bohan, Annelies Hickerson, Todd Smolinsky, Katryna Thomas, Jessica Cindass, John Hyngstrom, Adam C Berger, James Jakub, Jeffrey J Sussman, Montaser F Shaheen, Xianzhong Yu, Thomas E Wagner, Mark Faries, George E Peoples
Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis. Journal for immunotherapy of cancer 11 (8) (2023)

Spencer G Van Decar.css-eqlu8i{font-size:small;padding-left:4px;} (Spencer Van Decar)

Publication Activity (10 Years)

Top Topics

Top Venues

Spencer G Van Decar (Spencer Van Decar)